Advancing the Standard of Care for Fragile, Mature Skin
Are you up to date on this groundbreaking study recently published in the JDD?
Dermatoporosis and skin fragility present unique clinical challenges, often manifesting through altered pH, pronounced crepiness, loss of firmness, easy bruising, and deep photodamage. Finding targeted topical interventions that effectively restore skin barrier integrity in aging skin remains a primary focus for dermatologic care providers.
A new 12 week multicenter clinical study featured in the Journal of Drugs in Dermatology evaluates a novel therapeutic cream, GC, specifically formulated for mature, fragile skin. Enrolling male and female subjects across diverse races, ethnicities, and Fitzpatrick skin types, researchers investigated the impact of twice daily application on dry, crepey skin of the knees and thighs.
The objective findings demonstrate statistically significant improvements in key skin quality parameters, including firmness, crepiness, and overall photodamage. Bioinstrumentation data revealed optimized skin hydration through Corneometer heatmapping alongside a favorable reduction in skin surface pH. Crucially, early enhancements in skin smoothness and texture were observed with zero reported adverse events, highlighting exceptional tolerability and high patient satisfaction.
As mature patients increasingly seek evidence-based options for fragile skin care, these clinical insights provide valuable guidance for structuring effective, highly tolerable regimens in practice. Review the complete study and data in the Journal of Drugs in Dermatology to explore how this specialized topical formulation performs across diverse clinical endpoints.
Blog write-up assisted by AI
